{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:19:35Z","timestamp":1793899175348,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.anai.2022.06.015","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T20:59:16Z","timestamp":1655758756000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Biologics in eosinophilic gastrointestinal diseases"],"prefix":"10.1016","volume":"130","author":[{"given":"Evan S.","family":"Dellon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-5353","authenticated-orcid":false,"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0001","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.anai.2021.04.036","article-title":"One march, many paths: insights into allergic march trajectories","volume":"127","author":"Gabryszewski","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cgh.2021.05.053","article-title":"Determination of biopsy yield that optimally detects eosinophilic gastritis and\/or duodenitis in a randomized trial of lirentelimab","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0003","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0004","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.anai.2020.03.020","article-title":"AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the management of eosinophilic esophagitis","volume":"124","author":"Hirano","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0005","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.anai.2020.03.021","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters","volume":"124","author":"Rank","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0006","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anai.2020.03.011","article-title":"Challenges with the technical review of eosinophilic esophagitis: discussion points for the practicing allergist","volume":"124","author":"Spergel","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2015.07.041","article-title":"Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis","volume":"14","author":"Lucendo","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0008","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","article-title":"Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.anai.2022.06.015_bib0009","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s10620-017-4642-7","article-title":"Six-food elimination diet and topical steroids are effective for eosinophilic esophagitis: a meta-regression","volume":"62","author":"Cotton","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.anai.2022.06.015_bib0010","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MPG.0000000000000865","article-title":"Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a national administrative database","volume":"62","author":"Jensen","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0012","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.anai.2019.09.011","article-title":"Eosinophilic gastrointestinal disorders: the journey to diagnosis remains arduous","volume":"124","author":"Chehade","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0013","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jaip.2020.12.054","article-title":"Diagnostic delay in patients with eosinophilic gastritis and\/or duodenitis: a population-based study","volume":"9","author":"Chehade","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.anai.2018.06.013","article-title":"Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis","volume":"121","author":"Egan","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.06.015_bib0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2468-1253(18)30005-0","article-title":"Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus","volume":"3","author":"Walker","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0016","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jaip.2019.01.053","article-title":"Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience","volume":"7","author":"Kennedy","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2022.06.015_bib0017","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.jaip.2019.03.020","article-title":"Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes","volume":"7","author":"Muir","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOG.0000000000000492","article-title":"Eosinophilic colitis and colonic eosinophilia","volume":"35","author":"Walker","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"issue":"13","key":"10.1016\/j.anai.2022.06.015_bib0019","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2021.14920","article-title":"Eosinophilic esophagitis: a review","volume":"326","author":"Muir","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaci.2018.05.008","article-title":"Epithelial origin of eosinophilic esophagitis","volume":"142","author":"Rochman","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O'Shea","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0022","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0023","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study","volume":"145","author":"Shoda","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0024","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1053\/j.gastro.2022.01.022","article-title":"Evaluating eosinophilic colitis as a unique disease using colonic molecular profiles: a multi-site study","volume":"162","author":"Shoda","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0025","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0027","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa'ad","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0028","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0029","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/MPG.0000000000001840","article-title":"Safety and efficacy of reslizumab for children and adolescents with eosinophilic esophagitis treated for 9 years","volume":"66","author":"Markowitz","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","article-title":"Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis","volume":"135","author":"Rothenberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0031","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.anai.2022.06.015_bib0032","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0033","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cgh.2015.08.040","article-title":"Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment [published correction appears in Clin Gastroenterol Hepatol. 2016;14(6):919]","volume":"14","author":"Dellon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2022.06.015_bib0034","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2020.03.045","article-title":"An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results","volume":"146","author":"Gann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0036","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cgh.2020.03.036","article-title":"Long-term efficacy and tolerability of RPC4046 in an open-label extension trial of patients with eosinophilic esophagitis","volume":"19","author":"Dellon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0037","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0038","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2010.07.048","article-title":"Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis","volume":"139","author":"Straumann","year":"2010","journal-title":"Gastroenterology"},{"issue":"Virtual meeting (#LB3)","key":"10.1016\/j.anai.2022.06.015_bib0039","article-title":"A phase 3, randomized, 3-part study to investigate the efficacy and safety of dupilumab in adult and adolescent patients with eosinophilic esophagitis: results from part A","author":"Dellon","year":"2020","journal-title":"American College of Gastroenterology Annual Meeting, ACG[#,\")\"][#,\".\"]?>"},{"issue":"October 2021","key":"10.1016\/j.anai.2022.06.015_bib0040","article-title":"LIBERTY EoE TREET: results from parts A and C of the Phase 3, randomized, 3-part LIBERTY EoE TREET study to investigate the efficacy and safety of Dupilumab in adult and adolescent patients with eosinophilic esophagitis up to 52 weeks","author":"Dellon","year":"2021","journal-title":"American College of Gastroenterology Annual Meeting ACG[#,\"(\"];[#,\")\"]?>"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0041","article-title":"Dupilumab improves clinical and histologic aspects of disease in adult and adolescent patients with eosinophilic esophagitis at week 24: results from part B of the 3-part LIBERTY EoE TREET study","volume":"149","author":"Rothenberg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2022.06.015_bib0042","article-title":"Clinical and histologic improvements with weekly dupilumab treatment in adult and adolescent patients with eosinophilic esophagitis at Week 24: weekly and every 2 week results from part B of the 3-part LIBERTY EoE TREET study","volume":"162","author":"Dellon","year":"2022","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.anai.2022.06.015_bib0043","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.anai.2022.01.019","article-title":"Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use","volume":"128","author":"Spergel","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"17","key":"10.1016\/j.anai.2022.06.015_bib0044","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0046","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2008.06.012","article-title":"Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis","volume":"122","author":"Straumann","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0047","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaci.2007.06.015","article-title":"Anti-IgE treatment of eosinophil-associated gastrointestinal disorders","volume":"120","author":"Foroughi","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0048","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.anai.2018.07.030","article-title":"Severe asthma with eosinophilic gastroenteritis effectively managed by mepolizumab and omalizumab","volume":"121","author":"Han","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2022.06.015_bib0049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13223-020-00423-3","article-title":"Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report","volume":"16","author":"Caruso","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"14","key":"10.1016\/j.anai.2022.06.015_bib0050","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-negative hypereosinophilic syndrome","volume":"380","author":"Kuang","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0051","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jaip.2022.02.037","article-title":"Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic gastrointestinal disease","volume":"10","author":"Kuang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0052","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/19420862.2017.1332553","article-title":"Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis","volume":"9","author":"Vicari","year":"2017","journal-title":"mAbs"},{"issue":"12","key":"10.1016\/j.anai.2022.06.015_bib0053","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.cgh.2018.03.024","article-title":"Vedolizumab treatment may reduce steroid burden and improve histology in patients with eosinophilic gastroenteritis","volume":"16","author":"Kim","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.anai.2022.06.015_bib0054","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41395-018-0145-1","article-title":"The anti-alpha4beta7 integrin therapeutic antibody for inflammatory bowel disease, vedolizumab, ameliorates eosinophilic esophagitis: a novel clinical observation","volume":"113","author":"Nhu","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.anai.2022.06.015_bib0055","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-019-05617-3","article-title":"Eosinophilic gastroenteritis: clinical manifestation, natural course, and evaluation of treatment with corticosteroids and vedolizumab","volume":"64","author":"Grandinetti","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.anai.2022.06.015_bib0056","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","article-title":"Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis","volume":"150","author":"Safroneeva","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.anai.2022.06.015_bib0057","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJMp1504023","article-title":"Placebo effects in medicine","volume":"373","author":"Kaptchuk","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2022.06.015_bib0058","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jaci.2021.07.001","article-title":"Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)","volume":"149","author":"Collaborators","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.06.015_bib0059","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2020.01.051","article-title":"Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multi-site cohort","volume":"145","author":"Dunn","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622005361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622005361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:29:41Z","timestamp":1761053381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622005361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1081120622005361"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.06.015","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologics in eosinophilic gastrointestinal diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}